To further investigate whether upregulated BCL2A1 is associated with metastatic ovarian cancers, we first examined the expression of BCL2A1 in clinical ovarian cancer tissues or cells obtained from the primary ovaries, ascites, and lavage of ovarian cancer patients by Western blot analysis. The gene discussed is BCL2A1; the disease is ovarian carcinoma.